Vesper Bio ApS: Financial statements 2015
CVR: 32879861
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2015. In 2015, the company reported a net result of DKK -6,065,152 compared with DKK -6,940,347 the year before. Equity in the 2015 report amounted to DKK 7,069,129. The solvency ratio was 88.7%.
- Profit/Loss
- DKK -6,065,152
- Equity
- DKK 7,069,129
- Total Assets
- DKK 7,972,614
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | - | -6.1 mio. | 7.1 mio. | - |
| 2014 | - | - | -6.9 mio. | 5.6 mio. | - |
| 2013 | - | - | -2.6 mio. | 12.6 mio. | - |
| 2012 | - | -22 t. | -16 t. | 377 t. | - |
Official annual report
How creditworthy is Vesper Bio ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of September 25, 2015, LUNDBECKFONDEN is registered as an owner of Vesper Bio ApS with an ownership share of 66%.
Vesper Bio ApS has published its annual report for 2014. The net result was DKK -6,940,347.
About Vesper Bio ApS
Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity in the 2025 report amounted to DKK -227,433,239.